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old tuberculin and to tetanus antitoxin.
The present paper deals with the effects of
EACA on the tuberculin reaction in man, and
with the mechanisms through which they are
produced.
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METHODS
The subjects were 36 male tuberculin-sensitive
volunteers, 20—40 years old.f The antigens used
were purified protein derivative (PPD) or Koch
old tuberculin.t Test compounds injected with
tuberculin included EACA, lysine, histamine
phosphate, diphenhydramine IIC1. and chlor-
pheniramine. §In the experimental situation, 4 to 12 tuberculin
reactions were simultaneously elicited on the
backs of subjects. Since the antigenicity is greatly
altered by changes in pH of the medium, a 1%
solution of a Na-K phosphate buffer of pH 7.4
was used as solvent. The amount of antigen given
was varied according to the sensitivity of the
subject; the most frequently used dose was 1 pg
of old tuberculin. In all cases, the volume of each
injection was .05 cc. The test compound was mixed
with the tuberculin immediately prior to injec-
tion; in certain situations to be described later,
the test compound was injected separately. In
the case of lysine solutions, it was necessary to
adjust the pH to 7.4 by addition of one or two
drops of 2 N NaOH.
For each injection of tuberculin with an experi-
mental compound, there was an untreated control
injection. Location on the back of experimental
and control lesions was varied so as to minimize
regional differences in reactivity.
Test sites were observed 48 hours after injec-
tion of the antigen, at which time the horizontal
diameter of erythema of the lesions was measured.
All measurements were made by an assistant who
did not know the nature of the compounds in-jected. These data are most conveniently pre-
sented as percentages, expressing the ratios of
diameters of test to control lesions; median per-
centages are used as a measure of central tendency.
The differences in the number of percentages
above and below 100% (which by chance should
approach equality) were evaluated statistically by
means of Chi square.
RESULTS AND DISCUSSION
A synopsis of results is presented in Table I.
It is apparent that injection of 1.5 mgm EACA
f Subjects were inmates at Philadelphia County
Prison, Holmesburg.t PPD was the commercial product of Merck,Sharpe and Dohme. Tuberculin solutions, pre.-
pared weekly from Wyeth Koch Old Tuberculin,
were generously supplied by Dr. Edward Steers.
§ EACA was generously supplied by William
Sweeney, M.D., Lederle Laboratories, Chlor-
phenirainine was a gift of Marshall Guthrie, M.D.,Smith Kline and French Laboratories. Other
conipounds were obtained commercially.
Epsilon-amino caproic acid (EACA) is an
thhibitor of plasminogen activators (1, 2) which
has been used clinically to prevent bleeding (3).
It has also been reported to have various anti-
thflammatory and "anti-allergic" effects, pre-
sumably by virtue of its anti-fibrinolytic and
anti-proteolytic qualities.
For instance, Zweifach et at. (4) report that
EACA, given systemically, can attenuate a
necrotizing skin reaction to an endotoxin in the
rabbit; they attribute this effect to the inhibition
of proteolytic enzymes. Other anti-inflammatory
effects claimed for this drug include the inhibi-
tion of allergic anaphylaxis in the rabbit (5), a
decrease in vascular reactions to histamine in the
rat (6), and inhibition of in vitro formation of
certain pyrogens (7). The inhibition of in vitro
precipitation of antigen-antibody complexes by
EACA and several structurally related com-
pounds has recently been observed by Atchley
and Bhagavan (8).
In the realm of dermatology, systemic ad-
ministration of EACA has been reported to be of
value in the treatment of some acute dermatitides
(9). In an experimental situation,. Itoga and Yogo
(10) have reported that local injection of EACA
can inhibit or diminish the reaction to tuberculin
(type not specified) in human skin. More re-
cently, Stacher (11) has also reported that ad-
ministration of EACA can diminish reactions to
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Test solution (.05 cc)
EACA 1%
EACA 3%
EACA 3% (dialysed)
EACA 5% (injected sepa-
rately)
EACA 5% (injected sepa-
rately 3 hrs later)
Histamine 0002-02%
Lysine 2.7%
Lysine 1—1jv%
EACA 3% plus chlor-
phenirarnine .01—1%.
Chlorpheniramine.01—1%..
z
(.05cc of a 3% solution) with tuberculin decreases
the size of the tuberculin reaction seen 48 hours
later. The sma]ler dose studied had little, if any
effect. The effect of EACA is more observable
when small amounts of tubercu]in (e.g. 1 jig)
are injected than with larger doses. For unknown
reasons, the effect was slight or absent when
PPD is used as antigen, even though very small
amounts were used. The data presented in the
table include all experiments with old tuber-
culin, but none with PPD.
The possibility arises that EACA may simply
denature or inactivate the tuberculin when it is
mixed with it in the syringe prior to injection.
However, when EACA was mixed with tuber-
culin, and then dialyzed away overnight, the
antigenicity of the tuberculin was found to be
intact. When EACA and tuberculin were injected
separately into the same site, so that EACA
was not mixed with tuberculin prior to injection,
the tuberculin reaction was again decreased by
EACA. In this last experiment, a 5% solution
of EACA was required to produce a significant
effect; control sites were injected with an equal
volume of the buffer solution. These experiments
]ead to the conclusion that EACA does not alter
tuberculoprotein itself, but must alter the way it
is "active" in the skin.
Another approach toward unravelling the
mechanism by which EACA diminishes the tuber-
culin reaction is suggested by the repeated ob—
servation that EACA produces an immediate
wheal and flare when injected into the skin.
When an antihistaminic compound, such as
diphenhydramine or chlorpheniramine, is added
Proba- to the solution, both wheal and flare are nearly
bility abolished; hence it seems likely that EACA re-
leases histamine in the skin. Pepys (12) has shown
that local injection of histamine can reduce the
N S size of the tuberculin reaction, and Seeberg, in a
classic monograph (13), has reported that topical
NS. histamine, as well as several other vasodilating
agents (such as ultra-violet light), has the same
<.01 effect. Both of these authors suggest that the
circulatory changes produced by histamine
N.S. result in an acceleration of removal of the tuber-
<.001 culin from the site of injection.
<.02 This suggests that at least a part of the effect
<.01 of EACA on the tuberculin reaction may be
< secondary to histamine release. Our next step
<01 was a comparison of the effects of EACA with
those of histamine. Both compounds were in-
jected with tuberculin in the same subjects at
the same time; an amount of histamine was used
which elicited wheal and flare about the same
size as that produced by EACA. As can be seen
in the table, the effects of EACA and histamine
on the size of the tuberculin reaction were quite
similar.
Further evidence that the effect of EACA on
the tuberculin reaction is related to its whealing
effect is the finding that lysine (e,a diaminocaproic
acid), which is a much more potent whealing
agent than EACA (but, in contrast to EACA,
is not a good antifibrinolytic agent) is a more
powerful depressor of the tuberculin reaction
than EACA. Thus, a 1% solution of lysine signifi-
cantly attenuates the tuberculin reaction, while
a 3% solution of EACA was required to do so.
In six cases in which .05cc of a 5% solution of
EACA was injected into the site 3 hours after
injection of tuberculin, no effect on the size of
the resulting reaction was seen. This observation
lends circumstantial support to the hypothesis
that the effect of EACA on the tuberculin re-
action is due to washing away of the antigen
before the allergic reaction can be initiated.
If the effect of EACA on the tuberculin re-
action is due to histamine release, then it should
be possible to abolish its effect by addition of an
antihistamine to the mixture injected. As can
be seen in the table, addition of a small amount
of chlorpheniramine to the EACA-tuberculin
mixture does tend to decrease the effect of EACA
TABLE I
Diameter of test reaction as percentage
of control diameter
Q
z
13
63
10
11
6
42
11
16
25
16
5
25
4
5
2
11
4
7
11
11
89
70
100
80
112
73
60
62
86
75
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on tile tuberculin reaction, although it is not
abolished entirely. However, attempts to do
this experiment in a definitive way have been
frustrated so far by the finding that many anti-
histaminic cornpound (e.g.: chlorpheniramine,
diphenhydrarnine) exert an effect of their own
on the tuberculin reaction, decreasing its size
when locally injected in concentrations which
will inhibit the wheal produced by EACA.
Partial inhibition of the tuberculin reaction by
an antihistamine has been reported before (14);
the mechanism of action has not been studied.
At this stage of investigation, it is obvious
that some, if not all, of the effect of EACA on
the tuberculin reaction is due to its whealing
ability, rather than to its antifibrinolytic or
antiproteolytic qualities. The concept of EACA
as a histamine-releaser may also explain Otto-
Sevais and Lecomte's report of inhibition of
anaphylaxis in the rabbit by pre-treatment
with EACA. Such pretreatment may simply have
depleted the supply of histamine available for
producing anaphylaxis later.
It goes without saying that we cannot exclude
the possibility that EACA has some additional
effect on the tuberculin reaction beside those
due to histamine release. Such possibihties in-
clude: a) "irritant" vascu]ar effects promoting
removal of antigen other than those of histamine,
and b) specific anti-inflammatory or immunologic
effects.
SUMMAIY
Previous reports that local injection of EACA
can attenuate the tuberculin reaction were
verified. Further study suggests that this effect
is at least in part due to the fact that EACA
is a whealing agent. Its inhibitory effect on the
tuberculin reaction is mimicked by a similar
wheal produced by histamine; and is exceeded by
equimolar injection of lysine, which is a more
potent whealing agent than EACA. An incidental
observation was partial inhibition of the tuber-
culin reaction by local injection of chiorphenir-
amine or diphenhydramine.
A1)DENI)UM
Since this manuscript was submitted for
publication, reports have appeared suggesting
that systemic EACA may be of value in treat-
ment of atopic dermatitis (Arnet et al.: Dermato-
logica, 127: 94, 1963) and in seleroderma (Rotstein
et al.: J.A.M.A., 184: 517, 1963). Prolongation
of hornogiaft survival has been claimed for EACA
(Gillette et al.: Proc. Soc. Exper. Biol. Med., 112:
964, 1963, and Transplantation, 1: 116, 1963)
and for a related compound (Bertelli et al.:
Nature, 197: 510, 1963). Magnussen has published
a paper on suppression of the tuberculin reaction
by histamine (Acta Dermato-Vener., 43: 206,
1963).
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